In 1945, philanthropist Alfred P. Sloan and inventor Charles F. Kettering founded the Sloan Kettering Institute (SKI) on New York City’s Upper East Side, with the vision of harnessing the latest research techniques in order to conquer cancer. As Mr. Sloan said at the time, “The scientific policy of the Institute rests upon the principle that basic advances through research are made only by the creative genius of individual scientists.”In 1960, Memorial Sloan Kettering Cancer Center was established as the corporate entity that would coordinate and guide overall policy for both Memorial Hospital and SKI. Twenty years later, SKI, Memorial Hospital, and Memorial Sloan Kettering Cancer Center were unified into a single institution. Through the years, Sloan Kettering Institute has endeavored to lead the way in biomedical research, frequently translating scientific advances into innovative medical applications.
Facts & Figures
Today, research activities of the Sloan Kettering Institute are organized as nine research programs:
- Cancer Biology & Genetics
- Cell Biology
- Chemical Biology
- Computational Biology
- Developmental Biology
- Molecular Biology
- Molecular Pharmacology
- Structural Biology
Under the leadership of Joan Massagué, the Sloan Kettering Institute’s research staff includes more than 100 laboratory investigators, 400 research fellows, and 200 graduate students (both PhDs and MD/PhDs). SKI boasts many National Academy of Sciences members and Howard Hughes Medical Institute investigators.
Located in the research corridor of Manhattan’s Upper East Side, the Sloan Kettering Institute enjoys a close collaboration with neighbors Cornell University, its Weill Medical College, and The Rockefeller University.
Education and Training
The Sloan Kettering Institute offers a host of training programs, including a Tri-Institutional MD-PhD Program, PhD Programs, and the Summer Research Internship Program.
Commitment to the Future
In fall 2006, Memorial Sloan Kettering nearly doubled the size of its research enterprise with the official opening of a new research complex, named in recognition of a $100 million gift from Memorial Sloan Kettering Boards member Mortimer B. Zuckerman.
The first new research facility for Memorial Sloan Kettering since 1989, the Mortimer B. Zuckerman Research Center’s 23-story building is uniquely designed to provide researchers with an inspiring, interactive, and efficient environment in which they can work together. A second phase of construction is now under way to build a connecting seven-story structure.